Study: NCT02622074

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg administered Q3W as an IV infusion.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg administered Q3W as an IV infusion.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg administered Q3W as an IV infusion.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg administered Q3W as an IV infusion.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg administered Q3W as an IV infusion.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg administered Q3W as an IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: 125 mg/m\^2 or 100 mg/m\^2 administered weekly as an IV infusion, according to allocation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: 125 mg/m\^2 or 100 mg/m\^2 administered weekly as an IV infusion, according to allocation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: 125 mg/m\^2 or 100 mg/m\^2 administered weekly as an IV infusion, according to allocation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: 125 mg/m\^2 or 100 mg/m\^2 administered weekly as an IV infusion, according to allocation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anthracycline (doxorubicin)
Description: 60 mg/m\^2 administered Q3W as an IV injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anthracycline (doxorubicin)
Description: 60 mg/m\^2 administered Q3W as an IV injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anthracycline (doxorubicin)
Description: 60 mg/m\^2 administered Q3W as an IV injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anthracycline (doxorubicin)
Description: 60 mg/m\^2 administered Q3W as an IV injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anthracycline (doxorubicin)
Description: 60 mg/m\^2 administered Q3W as an IV injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anthracycline (doxorubicin)
Description: 60 mg/m\^2 administered Q3W as an IV injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 600 mg/m\^2 administered Q3W as an IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 600 mg/m\^2 administered Q3W as an IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 600 mg/m\^2 administered Q3W as an IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 600 mg/m\^2 administered Q3W as an IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 600 mg/m\^2 administered Q3W as an IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 600 mg/m\^2 administered Q3W as an IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC 6 or AUC5 administered Q3W as an IV infusion, or AUC2 administered weekly as an IV infusion, according to allocation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC 6 or AUC5 administered Q3W as an IV infusion, or AUC2 administered weekly as an IV infusion, according to allocation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC 6 or AUC5 administered Q3W as an IV infusion, or AUC2 administered weekly as an IV infusion, according to allocation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC 6 or AUC5 administered Q3W as an IV infusion, or AUC2 administered weekly as an IV infusion, according to allocation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC 6 or AUC5 administered Q3W as an IV infusion, or AUC2 administered weekly as an IV infusion, according to allocation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 80 mg/m\^2 or 70 mg/m\^2 administered weekly as an IV infusion, according to allocation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 80 mg/m\^2 or 70 mg/m\^2 administered weekly as an IV infusion, according to allocation.